ERIC KING: Open Payments
NPI 1427101922 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,504 in 110 payments from 17 companies in 2025. Trend: 2023 $1,925 · 2024 $2,495 · 2025 $2,504
Food & beverage: $2,357Education: $147
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 23 | $528 |
| Janssen Biotech, Inc. | 16 | $379 |
| Regeneron Healthcare Solutions, Inc. | 11 | $360 |
| Lilly USA, LLC | 15 | $338 |
| Galderma Laboratories, L.P. | 19 | $277 |
| GENZYME CORPORATION | 6 | $192 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 2 | $66 |
| LEO Pharma Inc. | 3 | $61 |
| PFIZER INC. | 3 | $52 |
| Botanix SB Inc | 3 | $52 |
Products named: DUPIXENT, TREMFYA, SKYRIZI, NEMLUVIO, TALTZ, RINVOQ, EBGLYSS, ILUMYA.
Industry payments across IL — which companies pay providers there.
